Sign in

CIK 0001971387 · <br>Emerging growth company

Liminatus Pharma, Inc.

Sign in to watch
Ticker
LIMN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
213-273-5453
Business address
12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
Former names
Iris Parent Holding Corp.

Securities

  • LIMN Class A Common Stock Nasdaq
  • LIMNW Warrants Nasdaq
  1. S-1 Offering Registration Statement
  2. 424B3 Offering Prospectus
  3. 424B4 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1 Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. 424B3 Offering Prospectus
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1/A Offering Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. S-1 Offering Registration Statement
  14. 424B3 Offering Prospectus
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. 424B3 Offering Prospectus

Page 1 of 2 · 31 filings